Rezolute, Inc. - Common Stock (NV) (NQ:RZLT)
3.845
+0.215
(+5.92%)
Streaming Delayed Price
Updated: 11:48 AM EST, Feb 13, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 1,586,226 |
| Open | 3.610 |
| Bid (Size) | 3.840 (700) |
| Ask (Size) | 3.850 (1,800) |
| Prev. Close | 3.630 |
| Today's Range | 3.580 - 3.855 |
| 52wk Range | 1.070 - 11.46 |
| Shares Outstanding | 57,943,066 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Which stocks are gapping on Wednesday? ↗
December 24, 2025
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
December 17, 2025
Unusual volume stocks in Monday's session ↗
December 15, 2025
Unusual volume stocks in Friday's session ↗
December 12, 2025
Frequently Asked Questions
Is Rezolute, Inc. - Common Stock (NV) publicly traded?
Yes, Rezolute, Inc. - Common Stock (NV) is publicly traded.
What exchange does Rezolute, Inc. - Common Stock (NV) trade on?
Rezolute, Inc. - Common Stock (NV) trades on the Nasdaq Stock Market
What is the ticker symbol for Rezolute, Inc. - Common Stock (NV)?
The ticker symbol for Rezolute, Inc. - Common Stock (NV) is RZLT on the Nasdaq Stock Market
What is the current price of Rezolute, Inc. - Common Stock (NV)?
The current price of Rezolute, Inc. - Common Stock (NV) is 3.845
When was Rezolute, Inc. - Common Stock (NV) last traded?
The last trade of Rezolute, Inc. - Common Stock (NV) was at 02/13/26 11:48 AM ET
What is the market capitalization of Rezolute, Inc. - Common Stock (NV)?
The market capitalization of Rezolute, Inc. - Common Stock (NV) is 222.79M
How many shares of Rezolute, Inc. - Common Stock (NV) are outstanding?
Rezolute, Inc. - Common Stock (NV) has 223M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.